Literature DB >> 20516204

TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects.

Jose de Jesus Garduño-Garcia1, Ulices Alvirde-Garcia, Guadalupe López-Carrasco, Ma Elena Padilla Mendoza, Roopa Mehta, Olimpia Arellano-Campos, Ricardo Choza, Leobardo Sauque, Maria Eugenia Garay-Sevilla, Juan Manuel Malacara, Francisco J Gomez-Perez, Carlos A Aguilar-Salinas.   

Abstract

OBJECTIVE: To examine the association between thyroid function and the components of the metabolic syndrome and insulin resistance in an Hispanic population.
DESIGN: Cross-sectional study.
METHODS: Subjects with no history of thyroid disease or diabetes were included. Thyroid function was stratified as euthyroid or subclinical hypothyroidism (SCH) status and subsequently by free thyroxine (FT(4)) and TSH tertiles. The association of the metabolic syndrome components (defined by 2004 Adult Treatment Panel III criteria) and insulin resistance with thyroid status, TSH, and FT(4) were examined.
RESULTS: A total of 3148 subjects were analyzed. The prevalence of SCH was 8.3%. The prevalence of the metabolic syndrome was similar in euthyroid and SCH patients (31.6 vs 32.06%, P=0.89). Total cholesterol was higher in patients with SCH (5.51+/-1.19 vs 5.34+/-1.05 mmol/l, P<0.032). Serum TSH values showed a positive correlation (adjusted for age and sex) with total cholesterol, triglycerides, and waist circumference. In contrast, FT(4) showed a positive correlation with high-density lipoprotein cholesterol, and an inverse correlation with waist circumference, insulin, and HOMA-IR.
CONCLUSION: SCH is not associated with an increased risk for the metabolic syndrome (as conceived as a diagnostic category defined by the National Cholesterol, Education Program, Adult Treatment Panel III criteria). Despite this, low thyroid function (even in the euthyroid state) predisposes to higher cholesterol, glucose, insulin, and HOMA-IR levels. The combined use of TSH and FT(4), compared with the assessment based on only FT(4), is a more convenient approach to evaluate the association between thyroid function and metabolic variables.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516204     DOI: 10.1530/EJE-10-0312

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  74 in total

1.  Prevalence of thyroid dysfunction in healthy adults according to the estimated iodine intake in 24-hour urine samples: The SALMEX cohort.

Authors:  Armando Flores-Rebollar; Iván Pérez-Díaz; Olynka Vega-Vega; Raúl Rivera-Moscoso; Reynerio Fagundo-Sierra; Sergio L Carbajal-Morelos; Hillary K Osorio-Landa; María G López-Carrasco; Ana R Lira-Reyes; Ricardo Correa-Rotter
Journal:  Eur J Nutr       Date:  2020-05-03       Impact factor: 5.614

2.  Thyroid hormones and thyroid disease in relation to perchlorate dose and residence near a superfund site.

Authors:  Ellen B Gold; Benjamin C Blount; Marianne O'Neill Rasor; Jennifer S Lee; Udeni Alwis; Anup Srivastav; Kyoungmi Kim
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-09-12       Impact factor: 5.563

3.  Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women?

Authors:  Anna Boggio; Fulvio Muzio; Michela Fiscella; Domenico Sommariva; Adriana Branchi
Journal:  Intern Emerg Med       Date:  2011-12-28       Impact factor: 3.397

4.  Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study.

Authors:  Avantika C Waring; Nicolas Rodondi; Stephanie Harrison; Alka M Kanaya; Eleanor M Simonsick; Iva Miljkovic; Suzanne Satterfield; Anne B Newman; Douglas C Bauer
Journal:  Clin Endocrinol (Oxf)       Date:  2012-06       Impact factor: 3.478

5.  TSH levels are associated with vitamin D status and seasonality in an adult population of euthyroid adults.

Authors:  I Barchetta; M G Baroni; F Leonetti; M De Bernardinis; L Bertoccini; M Fontana; E Mazzei; A Fraioli; M G Cavallo
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

Review 6.  Thyroid function and obesity.

Authors:  Peter Laurberg; Nils Knudsen; Stig Andersen; Allan Carlé; Inge Bülow Pedersen; Jesper Karmisholt
Journal:  Eur Thyroid J       Date:  2012-09-22

7.  Correction of Hypothyroidism Leads to Change in Lean Body Mass without Altering Insulin Resistance.

Authors:  Sangeetha Sirigiri; Suresh Vaikkakara; Alok Sachan; P V L N Srinivasarao; Sunil Epuri; Sailaja Anantarapu; Arun Mukka; Srinivasa Rao Chokkapu; Ashok Venkatanarasu; Ravi Poojari
Journal:  Eur Thyroid J       Date:  2016-09-08

8.  Thyroid Function and High-Sensitivity C-Reactive Protein in Cross-Sectional Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Effect of Adiposity and Insulin Resistance.

Authors:  Érique José F Peixoto de Miranda; Márcio Sommer Bittencourt; Itamar S Santos; Paulo A Lotufo; Isabela M Benseñor
Journal:  Eur Thyroid J       Date:  2016-09-02

9.  Hormetic effect of triiodothyronine in metabolically healthy obese persons.

Authors:  Ji Eun Jun; Tae Hyuk Kim; Seung-Eun Lee; You-Bin Lee; Jae Hwan Jee; Ji Cheol Bae; Sang-Man Jin; Kyu Yeon Hur; Jae Hyeon Kim; Sun Wook Kim; Jae Hoon Chung; Yong-Ki Min; Moon-Kyu Lee
Journal:  Endocrine       Date:  2017-07-19       Impact factor: 3.633

Review 10.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.